COMP <GO>
EPC vs ODD // RETURN ON INVESTED CAPITAL (ROIC)
Edgewell Personal Care Company (NYSE) VS. ODDITY Tech Ltd. (Class A) (NASDAQ) • 15-METRIC TALLY: EPC 4
— ODD 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ODD
LAST: $28.57 (+3.25%) • MKT CAP: $1.32B
roic
2.50%
LAST: $21.69 (+3.93%) • MKT CAP: $1.23B
roic
85.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EPC VS. ODD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EPC | ODD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.60% | 72.70% | -31.10 | ODD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 2.50% | 85.00% | -82.50 | ODD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.4x | 6.8x | +22.60 | ODD | /valuation <GO> |
| Free Cash Flow Yield | 8.99% | 6.81% | +2.18 | EPC | /fcf-yield <GO> |
| Operating Margin | 4.30% | 14.70% | -10.40 | ODD | /operating-margins <GO> |
| Net Profit Margin | 1.10% | 13.70% | -12.60 | ODD | /net-margins <GO> |
| Revenue Growth (YoY) | -1.30% | 25.20% | -26.50 | ODD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.23% | 0.00% | +2.23 | EPC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.58 | 2.95 | -1.37 | ODD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 55.1 | +0.47 | EPC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 48.2x | 9.3x | +38.90 | ODD | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.32B | $1.23B | $87.9M | EPC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EPC REV | ODD REV | EPC GROSS % | ODD GROSS % | EPC FCF | ODD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.22B | $809.8M | 41.6% | 72.7% | $118.4M | $83.6M |
| FY 2024 | $2.25B | $647.0M | 42.4% | 72.4% | -$231.0M | $134.5M |
| FY 2023 | $2.25B | $508.7M | — | — | -$216.1M | $87.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EPC // BETA —
ODD // BETA —